Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.5149
-0.7051 (-57.80%)
At close: May 22, 2026, 4:00 PM EDT
0.4100
-0.1049 (-20.37%)
Pre-market: May 26, 2026, 5:42 AM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Discovery and Development of Biopharmaceutical Products | 3.20K | 133.99K | 645.18K | 933.72K | 105.03K | | | | |
Discovery and Development of Biopharmaceutical Products Growth | -97.62% | -79.23% | -30.90% | 788.96% | - | | | | |
| 3.20K | 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -97.62% | -79.23% | -30.90% | 788.96% | - | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 3.20K | 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -97.62% | -79.23% | -30.90% | 788.96% | - | | | | |
| 3.20K | 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -97.62% | -79.23% | -30.90% | 788.96% | - | | | | |
Source: S&P Global Market Intelligence.
